{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05326451",
            "orgStudyIdInfo": {
                "id": "HSC-MS-21-1065"
            },
            "organization": {
                "fullName": "The University of Texas Health Science Center, Houston",
                "class": "OTHER"
            },
            "briefTitle": "Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Disease",
            "officialTitle": "Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Disease",
            "therapeuticArea": [
                "Other"
            ],
            "study": "home-based-transcranial-direct-current-stimulation-open-trial-for-behavioral-and-cognitive-symptoms-in-huntington-s-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-06-21",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-05-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-05-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-04-05",
            "studyFirstSubmitQcDate": "2022-04-05",
            "studyFirstPostDateStruct": {
                "date": "2022-04-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Erin Furr Stimming",
                "investigatorTitle": "Professor",
                "investigatorAffiliation": "The University of Texas Health Science Center, Houston"
            },
            "leadSponsor": {
                "name": "The University of Texas Health Science Center, Houston",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to assess feasibility, acceptability, and safety of providing transcranial direct current stimulation( tDCS) to Huntingtons Disease (HD) patients in the early to middle stages and to assess the efficacy of tDCS for HD-related behavioral, cognitive and other symptoms"
        },
        "conditionsModule": {
            "conditions": [
                "Huntington Disease"
            ],
            "keywords": [
                "transcranial direct current stimulation"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "active tDCS",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Device: active tDCS"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "active tDCS",
                    "description": "Participants will receive active tDCS with a constant current intensity of 2mA. Anodal tDCS will be applied to the left dorsolateral prefrontal cortex, while cathodal electrode will be positioned on the right dorsolateral prefrontal cortex. Caregivers will help setting up and administering tDCS for participants with HD at home. tDCS will be applied for 30min at an intensity of 2mA, with 30 s ramping up and down. Sessions will be remotely supervised by trained research staff (RA), and will run from Monday through Friday for four consecutive weeks.",
                    "armGroupLabels": [
                        "active tDCS"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Feasibility as assessed by the number of participants included and who successfully completed the protocol",
                    "timeFrame": "through study completion, an average of 8 weeks"
                },
                {
                    "measure": "Change in acceptability of the treatment as assessed by the tDCS acceptability questionnaire",
                    "description": "Acceptability will be evaluated using a Likert scale (from 0 \\[strongly disagree\\] to 10 \\[strongly agree\\]) to answer ten affirmatives regarding the use of home based tDCS, with a total score range of 0-10 and a higher score indicating higher acceptability.",
                    "timeFrame": "Baseline, week 2, week 4, week 8"
                },
                {
                    "measure": "Change in safety of home-based tDCS treatment as as assessed by the tDCS side effect questionnaire",
                    "description": "Safety will be assessed with a 10-item questionnaire about side effects, including itching, burning, headache, fatigue, and dizziness. Each question is scored form 0-10, with a total score range of 0-10 and a higher score indicating more side effects.",
                    "timeFrame": "week 2, week 4"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Motor function as assessed by the Unified Huntington Disease Rating Scale (UHDRS)",
                    "description": "The motor section of the UHDRS consists of 31 items rated on a 5-point ordinal scale ranging from 0 to 4, with a score of 0 indicating no abnormalities and 4 indicating the most severe impairment. Total score range is 0 to 124, with a higher score indicating decreased inability to perform motor tasks.",
                    "timeFrame": "Baseline,week4"
                },
                {
                    "measure": "Change in Cognitive function as assessed by the Unified Huntington Disease Rating Scale (UHDRS)",
                    "description": "The cognitive function section of the UHDRS consists of 5 items rated on a 5-point ordinal scale ranging from 0- to 4, with a total score range of 0 to 20 and with a higher score indicating better cognitive performance.",
                    "timeFrame": "Baseline,week4"
                },
                {
                    "measure": "Change in Behavior as assessed by the Unified Huntington Disease Rating Scale (UHDRS)",
                    "description": "The behavioral section of the UHDRS consists of 11 items evaluating various behavioral signs and symptoms. Individuals are ranked on both severity and frequency on a 0 to 4 scale, with 0 being not present and 4 being severe and frequent. Total behavioral scores are calculated by summing the severity and frequency items, with a total score range of 0 (no behavioral symptoms) to 88 (most severe behavioral symptoms).",
                    "timeFrame": "Baseline,week4"
                },
                {
                    "measure": "Change in apathy as assessed by the Brief Dimensional Apathy Scale (bDAS)",
                    "description": "This scale consists of 9 questions, each scored from 0 (almost always) to 3 (hardly ever), with a total score range of 0 to 27 and a higher score indicating more apathy.",
                    "timeFrame": "Baseline, week 2, week 4, week 8"
                },
                {
                    "measure": "Change in depression as assessed by the Patient Health Questionnaire (PHQ-9)",
                    "description": "This questionnaire has 9 questions. with each scored form 0 (not at all) to 3 (nearly every day), with a total score range of 0 to 27 and a higher score indicating more depression.",
                    "timeFrame": "Baseline, week 2, week 4, week 8"
                },
                {
                    "measure": "Change in irritability as assessed by the Irritability Questionnaire",
                    "description": "This is a 21-item questionnaire, with each item scored form 0 (never) to 3 (most of the time), for a total score range of of 0 to 63 and a higher score indicating more irritability.",
                    "timeFrame": "Baseline, week 2, week 4, week 8"
                },
                {
                    "measure": "Change in cognition as assessed by the Montreal Cognitive Assessment (MoCA)",
                    "description": "MoCA is scored from 0 to 30, with a higher score indicating better performance.",
                    "timeFrame": "Baseline, week 2, week 4, week 8"
                },
                {
                    "measure": "Change in anxiety and depressive symptoms as assessed by the Hospital Anxiety and Depression Scale (HADS)",
                    "description": "HADS is a 14-item scale, with seven items each for anxiety and depression subscales. Scoring for each item ranges from 0 to 3, with a total score range of 0 to 42 and a total subscale score range of 0 to 21. A subscale score greater than 8 denotes anxiety or depression.",
                    "timeFrame": "Baseline, week 2, week 4, week 8"
                },
                {
                    "measure": "Change in behavioral symptoms as assessed by the Problem Behaviours Assessment (PBA-s)",
                    "description": "Each symptom is rated for severity on a 5-point scale : 0 = not at all; 1 = trivial; 2 = mild; 3 = moderate (disrupting everyday activities); and 4 = severe or intolerable. Each symptom is also scored for frequency on a 5-point scale as follows: 0 = symptom absent; 1 = less than once weekly; 2 = at least once a week; 3 = most days (up to and including some part of everyday); and 4 = all day, every day. Severity and frequency scores are multiplied to produce an overall 'PBA score' for each symptom.",
                    "timeFrame": "Baseline, 2 weeks of treatment, at the end of treatment (week 4) and 4 weeks post-treatment."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Participant:\n\nInclusion Criteria:\n\n* confirmed HD mutation carriers\n* early (stages 1 and 2) or moderate (stage 3) stages according to Shoulson-Fahn\n* exhibit mild to moderate behavioral symptoms, such as clinically diagnosed apathy, irritability, anxiety, depression, aggression and repetition\n* stable doses of medications for at least one month\n\nExclusion Criteria:\n\n* unstable medical conditions\n* history of epilepsy\n* metallic objects in the brain\n* clinical diagnosis of major cognitive disorder or dementia\n* Have risk of suicidal behavior, defined as any suicidal behavior or suicidal ideation of type 4\n\nCaregiver:\n\nInclusion Criteria:\n\n-willingness to participate in the study\n\nExclusion Criteria:\n\n-motor/cognitive symptoms related to Alzheimer's disease or Huntington's disease that might impair the ability to assist the participant during the research study.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Erin Stimming, MD",
                    "role": "CONTACT",
                    "phone": "(713) 500-7033",
                    "email": "Erin.E.Furr@uth.tmc.edu"
                },
                {
                    "name": "Thiago Macedo e Cordeiro, MD",
                    "role": "CONTACT",
                    "phone": "(713) 486-2559",
                    "email": "Thiago.MacedoeCordeiro@uth.tmc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Erin Stimming, MD",
                    "affiliation": "The University of Texas Health Science Center, Houston",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "The University of Texas Health Science Center at Houston",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Erin Stimming, MD",
                            "role": "CONTACT",
                            "phone": "713-500-7033",
                            "email": "Erin.E.Furr@uth.tmc.edu"
                        },
                        {
                            "name": "Thiago Macedo e Cordeiro, MD",
                            "role": "CONTACT",
                            "phone": "(713) 486-2559",
                            "email": "Thiago.MacedoeCordeiro@uth.tmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006816",
                    "term": "Huntington Disease"
                },
                {
                    "id": "D000019954",
                    "term": "Neurobehavioral Manifestations"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001480",
                    "term": "Basal Ganglia Diseases"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000003704",
                    "term": "Dementia"
                },
                {
                    "id": "D000002819",
                    "term": "Chorea"
                },
                {
                    "id": "D000020820",
                    "term": "Dyskinesias"
                },
                {
                    "id": "D000009069",
                    "term": "Movement Disorders"
                },
                {
                    "id": "D000020271",
                    "term": "Heredodegenerative Disorders, Nervous System"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000003072",
                    "term": "Cognition Disorders"
                },
                {
                    "id": "D000019965",
                    "term": "Neurocognitive Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21826",
                    "name": "Neurobehavioral Manifestations",
                    "asFound": "Cognitive Symptoms",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9875",
                    "name": "Huntington Disease",
                    "asFound": "Huntington's Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25603",
                    "name": "Ganglion Cysts",
                    "relevance": "LOW"
                },
                {
                    "id": "M16358",
                    "name": "Synovial Cyst",
                    "relevance": "LOW"
                },
                {
                    "id": "M4774",
                    "name": "Basal Ganglia Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6904",
                    "name": "Dementia",
                    "relevance": "LOW"
                },
                {
                    "id": "M6059",
                    "name": "Chorea",
                    "relevance": "LOW"
                },
                {
                    "id": "M22574",
                    "name": "Dyskinesias",
                    "relevance": "LOW"
                },
                {
                    "id": "M12029",
                    "name": "Movement Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M22092",
                    "name": "Heredodegenerative Disorders, Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M6301",
                    "name": "Cognition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21836",
                    "name": "Neurocognitive Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "T2852",
                    "name": "Huntington Disease",
                    "asFound": "Huntington's Disease",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}